CTAK Commercialization

About CorneaGen

CorneaGen is a commercial-stage company and a world-leading eye bank specializing in corneal transplant tissue and regenerative medicine. Its core offering is CTAK, a gamma-irradiated, sterile, and customized corneal tissue inlay, alongside a portfolio of surgical products like the EndoSerter and VisionGraft. The company leverages its extensive tissue processing capabilities, surgeon education programs, and strategic partnerships to address corneal blindness, positioning itself as an integrated provider in the ophthalmic surgery ecosystem.

Therapeutic Areas